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Open innovation, which refers to combining internal and external ideas and internal and external paths to market
in order to achieve advances in processes or technologies, is an attractive paradigm for structuring collaborations
between developed and developing country entities and people. Such open innovation collaborations can be
designed to foster true co-creation among partners in rich and poor settings, thereby breaking down hierarchies
and creating greater impact and value for each partner. Using an example from Concern Worldwide’s Innovations
for Maternal, Newborn & Child Health initiative, this commentary describes an early-stage pilot project built around
open innovation in a low resource setting, which puts communities at the center of a process involving a wide
range of partners and expertise, and considers how it could be adapted and make more impactful and sustainable
by extending the collaboration to include developed country partners.
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Looking to developing countries as a source of in-
novation has become a core business practice for a
number of Western-based, multi-national corporations
(MNCs). Innovation drives growth and success in busi-
ness, and MNCs spend billions of dollars every year
aimed at finding solutions to new or unmet needs. But
innovation is not easy, either to foster or to achieve.
And some observers feel that the United States’ historical
leadership in innovation is ebbing [1]. For example, Tyler
Cowen, a professor of economics at George Mason
University and author of The Great Stagnation, warns that
innovation in the United States has reached a plateau and
it may be facing a long period of stagnation [2].
Worries about where the next innovation would come
from, exacerbated by fear of competition from emerging
economies, led several MNCs to fundamentally change
longstanding ways of working. For decades companies
such as General Electric (GE) pursued global growth by
developing products at home and selling modified, often
stripped-down, versions to customers in emerging mar-
kets [3,4]. These products were often too expensive forCorrespondence: maria.carlson@concern.net
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reproduction in any medium, provided the orlarge segments of those markets or ill-suited to customer
needs and local contexts. This opened up opportunities
for local competitors to offer low-cost alternatives de-
signed to meet the needs of local customers. As growth in
demand for high-end products in rich countries slowed
and the quality of these low-cost alternatives improved,
these “growing giants” eventually “disrupted” conventional
markets and actors [5]. GE recognized that a sea change
was required, and went on intentionally to “disrupt them-
selves” through “reverse innovation,” referring to transfer-
ring innovation from emerging markets to conventional
markets contexts. For example, by committing billions of
dollars to create healthcare innovations and relying on
local teams in China and India that would substantially
lower costs, GE increased access and improved quality.
While even reverse innovation can be successful by
relying solely on internal organizational resources and
talent, retaining all research and development in-house
can be costly and slow, and limits access to creative
people and ideas that reside outside. In response, some
have taken reverse innovation a step further, embracing
“open innovation,” a term promoted by Henry Chesbrough
and with roots going back decades [6]. Open innovation is
a paradigm that refers to combining internal and external
ideas as well as internal and external paths to market tod. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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essentially making the boundary between an entity and its
environment more porous [7].
Open innovation can take various forms, from crowd-
sourcing to structured organizational alliances and strategic
co-ventures (see Figure 1). Pursuing an open innovation
strategy recognizes that good ideas can come from almost
anywhere, the “outside-in” dimension of open innovation,
but also emphasizes that capturing the value created from
this approach requires new ways of working and innova-
tive business models [8]. Intellectual property (IP) that
had previously been carefully guarded, for example, should
be shared and thus could create additional value through
licensing arrangements, joint ventures, or other strategic
collaborations, something Chesbrough refers to as the “in-
side-out” aspect of open innovation.Discussion
Despite radically different contexts, there are lessons to
be learned by developed country health systems from
experiences in developing countries, i.e., opportunities
for reverse innovation, where necessity and ingenuity
have overcome resource constraints to achieve positive
outcomes. In their landscaping of developed-developing
country partnerships, Syed et al. 2012 conclude that
there are at least ten areas of health care whereFigure 1 Networked open innovation. In contrast to classic closed innov
market its own ideas, in the new open innovation model, an enterprise uti
ways to bring products and services to market by deploying multiple path
represents the porous boundary between the enterprise and its network p
markets, more users, and having greater impact.developed countries have the most to learn from devel-
oping countries, including creative problem-solving,
local product manufacture, and social entrepreneurship
[9]. Most of the examples in the literature reviewed
focus on how discrete innovations or technologies gener-
ated in a developing country could be adapted to a devel-
oped country context following a typical reverse
innovation pathway. Since many innovations originating
in developing countries conform to “frugal innovation”
principles, i.e., they are ultra-low cost, durable, easy to
use, draw sparingly on raw materials and minimize envir-
onmental impact, they are often well suited to any health
sector under growing pressure to achieve better outcomes
at significantly lower costs [10]. Christensen et al. 2000
suggest that the U.S. healthcare system is ripe for disrup-
tion of entrenched, over-built technologies and systems
[11]. Beyond their argument that disruptive technologies
have a place in “curing” our health system, their proposal
that we need “diagnostic and therapeutic advances that
allow nurse practitioners to treat diseases that used to re-
quire a physician’s care” could undoubtedly be informed
by the vast experience in task shifting that human re-
source constraints have necessitated in low resource
settings.
Syed et al. 2012 note that new models for international
cooperation should be explored and it is in this vein
that early experience from the Concern Worldwide’sation, whereby an enterprise generates, develops, and brings to
lizes in-house ideas as well as those of its network partners and seeks
ways. The dashed line in this illustration, inspired by Chesbrough,
artners, enabling innovations to move easily in and out, reaching new
Figure 2 Concern Worldwide's Maker hub.
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vations for MNCH) initiative, which draws on private sec-
tor experience in promoting innovation, offers potential
insights.
Innovations for MNCH was conceived in the spirit of
open innovation and also embraces elements of disrup-
tive and frugal innovation. The goal of the initiative is to
identify, develop and test innovative ways to overcome
barriers mothers and infants face in accessing essential,
life-saving health services. In pursuit of ideas to test, In-
novations for MNCH seeks input directly from commu-
nity members, from unheard or unconventional voices
and people often excluded from healthcare planning and
decision-making in low resource contexts. Innovations
for MNCH’s path to open innovation aims to blend in-
sights from the “crowd” with those from a wide range of
experts in health, but also in such fields as cognitive in-
formatics, philosophy, finance and design thinking. Our
approach draws heavily on principles of human-centered
design, which puts target communities’ needs and expe-
riences at the center of program development and which
incorporates iterative, short-cycle, rapid prototyping prior
to pilot testing or establishing proof-of-concept. Ultim-
ately, each of the innovations emerging from this design
process will be rigorously evaluated and its feasibility for
implementation and impact at scale assessed. Even at this
intermediate stage, however, lessons learned from the
open innovation process used to shape the ideas being
pilot tested show promise for informing the design of mu-
tually beneficial long-term collaborations between entities
in developed and developing countries.
One Innovations for MNCH project in early stages of
implementation is tapping into local talent and creative
problem-solving to design and produce ultra-low-cost
supplies and equipment for a developing country context.
Various studies have shown that a large number of health
facilities either lack the basic equipment needed for clin-
ical maternal, newborn and child health service delivery,
or that items are present but not functional; the World
Health Organization estimated that up to 70% of labora-
tory and medical equipment is not in service in some low
resource settings [12]. This is often due to high procure-
ment or replacement costs, supply chain problems, or de-
signs that are not tailored to meet local needs [13].
Without reliable access to functional, high-quality and
cost-effective equipment and spare parts it is difficult to
translate increased demand for maternal, newborn and
child health services into lives saved.
The Innovations for MNCH Maker project is tackling
some of the core reasons for this lack of equipment by
forming an open innovation network (see Figure 2)
among local academic, medical, engineering and manu-
facturing partners, including “makers,” people who de-
sign, build, invent, hack, or simply make something [14].The maker movement is gaining credibility as a source
of frugal innovation and local communities of makers
are springing up around the globe, taking on challenges
in energy, technology, health, and numerous other fields
often with remarkable results. Innovations for MNCH is
targeting critical maternal, newborn and child health
equipment gaps in a large, urban hospital in Africa and
expects to generate and test working prototypes of
modified (“hacked”) or entirely re-conceived equipment
that have the potential to fill these gaps and still meet all
safety and operational standards [15]. Aside from testing
the efficacy and impact of specific pieces of equipment, In-
novations for MNCH also hopes to demonstrate the viabil-
ity of a particular approach to open innovation, that is, the
creation of a maternal, newborn and child health “Maker
Hub,” an ongoing collaboration or network among clinical
workers, biomedical engineers, “makers,” and others spe-
cifically formed to address maternal, newborn and child
health equipment challenges.
Within the proof-of-concept phase of this project, its po-
tential to achieve long-term sustainability and scale cannot
be fully evaluated. But the project was designed with these
ultimate objectives in mind, incorporating elements that
would make this a viable social enterprise, particularly if the
network is expanded regionally or internationally and struc-
tured as an open innovation collaboration or co-venture be-
tween developed and developing country entities. It might
be possible, for example, for the Maker Hub to form a col-
laboration with one of several U.S.-based entities that bring
together people, clients, and partners, including strategists,
researchers, engineers and designers in health care and
other industries to accelerate innovation, thereby linking
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and talent from each.
A “networked open innovation” structure for collabora-
tions between developed and developing country entities
offers attractions for both. The “network” structure changes
the definition of “outside-in,” since there is no single entity
whose boundaries define the “inside” or “outside.” Since the
network members would include both developed and de-
veloping country entities, the direction of the innovation
becomes less meaningful as all network members work to-
ward developing products and services to meet the
needs of similar market segments wherever they live.
MNCs recognize that many of today’s developing coun-
tries and regions are the emerging economies of tomor-
row. They want early access to and deep understanding
of these growth markets. A social enterprise such as the
Maker Hub, which is built around community engage-
ment and user-centered solutions, offers the potential
to tap into this knowledge. Social enterprises in devel-
oping countries tend to be entrepreneurial and nimble,
which can enliven a large, established research and de-
velopment program. Dormant intellectual property in-
side the developed country, private sector partner, when
licensed to developing country partner, becomes a new
revenue stream. Developed country partners, whether
for- or not-for-profit, can serve as a kind of “incubator”
and “accelerator” for the developing country partner by
providing access to sources of capital, both philan-
thropic and investment, and to knowledge and expertise
(e.g., legal, technical, management, financial) in laun-
ching and growing a successful organization. This model
of open innovation collaboration can be structured in a
variety of ways and might include but public and private
entities. Inherent in the organizational design, however,
should be the aim to create social and economic value for
all partners in alignment with their missions.
Rather than developing and then adapting, stripping
down, or retrofitting innovations for markets in one
setting or the other, this approach effectively co-
creates innovation, puts communities and clients at
the center of the design process, and aims to create
economic and social value for all partners on a more
equal footing from the outset. Though only one ex-
ample, this approach suggests that social innovation
can move more fluidly and structurally between devel-
oped and developing countries and become embedded
in a truly global innovation process.
Conclusions
Key ideas
 New models of collaboration between developed and
developing country entities that blend aspects of open
innovation, frugal innovation, and human-centereddesign could accelerate the adoption and increase the
impact of successful ideas and technologies.
 Innovations that benefit from local insight,
community input, and multi-disciplinary teams from
both developing and developed country contexts
could result in products and services that reach
more people more quickly and create social and
economic value in both settings.
 At a time when health systems in developed
countries are challenged to deliver improved
outcomes to more people at lower costs, there is
enormous opportunity, even need, for “disruption”
from technologies and processes originally
developed in low resource settings.
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